r several
years in the late 90's, and was instrumental during the Roche/Chugai merger
at the beginning of this millennium. He was also responsible for
establishing a new development center in Shanghai, China in 2007. Dr.
Holdener served on several executive committees at the departmental,
divisional, and corporate levels, which focused particularly on portfolio
strategies and functional excellence. Prior to joining Roche, Dr. Holdener
held positions as a clinical oncologist in hospital settings and academic
institutions, both in Switzerland and the United States.
Dr. Holdener received his Medical Degree from the University of Zurich
and Basel Medical School in Switzerland, and completed his fellowship in
Oncology at the University of Kansas Medical Center in the United States.
He is Board Certified in Internal Medicine and Oncology/Hematology in
Switzerland.
About PAREXEL International
PAREXEL International Corporation is a leading global
bio/pharmaceutical services organization, providing a broad range of
knowledge-based contract research, medical communications and consulting
services to the worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite time-to-market
and peak-market penetration, PAREXEL has developed significant expertise
across the development and commercialization continuum, from drug
development and regulatory consulting to clinical pharmacology, clinical
trials management, medical education and reimbursement. Perceptive
Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology
solutions, including medical imaging, to facilitate the clinical
development process. Headquartered near Boston, Massachusetts, PAREXEL
operates in 64 locations throughout 51 countries around the world, and has
approximately 7,000 employees. For more information about PAREXEL
International visit http://www.PAREXEL.com.
This
'/>"/>
SOURCE PAREXEL Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call2.
PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities3.
PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results4.
PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call5.
PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors6.
PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.7.
Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe8.
PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference9.
Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit10.
SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer11.
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer